DaTSCAN, a new molecular diagnostic, is launched.

This is the world’s first diagnostic agent for objective identification of Parkinson’s, a disease affecting one to two people in every 1,000.

DaTSCAN provides a clear visualisation of the contrast between a healthy and diseased brain, as shown here.

Other new products include NeoSpect for diagnosis of lung tumours, Optison, an ultrasound heart imaging agent, and TheraSeed and EchoSeed for prostate cancer therapy.